It all seemed too good to be true...
Commercialisation of the NAR system, 25% of US$250M NASDAQ listing, huge income potential from China, new contracts, etc, etc, etc...
So why the sell-off?
Could it simply be that the market got spooked by the last minute revisions required by the Beauwal Group and the subsequent delays in receiving the US$5m deposit?
If that is the case...and ECS announces receipt of same...then the shareprice is in for a big bounce.
The ASX has put ECS on record with their "please explain", where they said everything is still on track...so they better not be hiding anything.
If bad news does emerge, I suggest the ASX check the ID's of the recent big sellers!
Cheers!
- Forums
- ASX - By Stock
- buying opportunity?
It all seemed too good to be true...Commercialisation of the NAR...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECS (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online